Other Events ·
DataMEDS AI, Inc. entered into a settlement agreement on September 11, 2026, resolving litigation with Brian Norton…
MEDSDataMeds AI, Inc.
DataMEDS AI, Inc. entered into a settlement agreement on September 11, 2026, resolving litigation with Brian Norton and other selling holders regarding the Membership Interest Purchase Agreement. The company paid $450,000 in total consideration: $350,000 for the repurchase and extinguishment of 364,099 shares of common stock, and $100,000 to settle all other claims. Consequently, the company anticipates extinguishing approximately $19 million in liability from its consolidated balance sheet. The parties agreed to dismiss the Florida and Delaware actions with prejudice and exchange mutual releases. DataMEDS AI, Inc. operates in the healthcare technology industry, providing artificial intelligence solutions for pharmacy operations.